The essential critique, acknowledged by the authors, is that 29 matched patients is a very small study group regardless of their meticulous power analysis. It would not be surprising, fusion impact not withstanding, that the diabetic outcomes worsened in a larger study because of unrecognized confounders over time.
The take-home about the non-impact of fusion quality is valuable, but to accept that diabetes itself otherwise did not compromise clinical outcomes is a stretch. Epstein 1 reported a distinct difference in outcome in spine surgery in the diabetic and similarly Fei et al 2 in a total of 13,000 patients from 12 studies found that infection compromised spine surgery outcome in diabetics.
